Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Prostate Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cadherins Medicine & Life Sciences
Epithelial Cells Medicine & Life Sciences
Proteins Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Cells Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1995 2021

Research Output 1987 2017

  • 3796 Citations
  • 35 h-Index
  • 57 Article
  • 3 Review article
  • 1 Conference contribution

Fibulin-3 promotes muscle-invasive bladder cancer

Han, A. L., Veeneman, B. A., El-Sawy, L., Day, K. C., Day, M. L., Tomlins, S. A. & Keller, E. T. Sep 14 2017 In : Oncogene. 36, 37, p. 5243-5251 9 p.

Research output: Research - peer-reviewArticle

Urinary Bladder Neoplasms
Insulin-Like Growth Factor Binding Protein 5
7 Citations

HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone

Day, K. C., Hiles, G. L., Kozminsky, M., Dawsey, S. J., Paul, A., Broses, L. J., Shah, R., Kunja, L. P., Hall, C., Palanisamy, N., Daignault-Newton, S., El-Sawy, L., Wilson, S. J., Chou, A., Ignatoski, K. W., Keller, E., Thomas, D., Nagrath, S., Morgan, T. & Day, M. L. Jan 1 2017 In : Cancer Research. 77, 1, p. 74-85 12 p.

Research output: Research - peer-reviewArticle

Bone Neoplasms
Prostatic Neoplasms
Bone and Bones
Circulating Neoplastic Cells
4 Citations

ADAM15 is functionally associated with the metastatic progression of human bladder cancer

Hiles, G. L., Bucheit, A., Rubin, J. R., Hayward, A., Cates, A. L., Day, K. C., El-Sawy, L., Kunju, L. P., Daignault, S., Lee, C. T., Liebert, M., Hussain, M. & Day, M. L. Mar 1 2016 In : PLoS ONE. 11, 3, e0150138

Research output: Research - peer-reviewArticle

Urinary Bladder Neoplasms
urinary bladder neoplasms
41 Citations

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma

Hussain, M., Daignault, S., Agarwal, N., Grivas, P. D., Siefker-Radtke, A. O., Puzanov, I., MacVicar, G. R., Levine, E. G., Srinivas, S., Twardowski, P., Eisenberger, M. A., Quinn, D. I., Vaishampayan, U. N., Yu, E. Y., Dawsey, S., Day, K. C., Day, M. L., Al-Hawary, M. & Smith, D. C. Sep 1 2014 In : Cancer. 120, 17, p. 2684-2693 10 p.

Research output: Research - peer-reviewArticle

Confidence Intervals
8 Citations

Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer

Grivas, P. D., Day, K. C., Karatsinides, A., Paul, A., Shakir, N., Owainati, I., Liebert, M., Kunju, L. P., Thomas, D., Hussain, M. & Day, M. L. 2013 In : Molecular Medicine. 19, 1, p. 367-376 10 p.

Research output: Research - peer-reviewArticle

Urinary Bladder Neoplasms
PF 00299804
Drug Therapy
Epidermal Growth Factor Receptor